Answers are grounded in this paper and cite their sources.
In our management of the preterm infant in need of respiratory support, we are currently grappling with competing priorities.Avoiding intubation at the beginning of life (other than for advanced resuscitation) appears to be a sensible proposition, both in infants ≤ 29 weeks gestation, 1 and certainly in those beyond 29 weeks.On the other hand, avoiding intubation means forgoing the usual conduit to deliver surfactant, the very drug that over the years has been our security blanket in dealing with the scourge of respiratory distress syndrome (RDS).Combining continuous positive airway pressure (CPAP) with selective surfactant delivery in a minimally-invasive protocol offers a great deal of promise for preterm infants of all gestations, 2,3 avoiding the pitfalls of mechanical ventilation no matter how expertly applied.Simply put, what is needed is an approach where we can recognize at an early stage the infants on CPAP who have significant RDS, and selectively administer surfactant to these infants without resorting to intubation.But at present, the path toward this simple goal is beset by confusion and uncertainty.It is not yet clear which infants to select, and what to take into account.What combination of CPAP pressure level, FiO 2 , and age, and for which gestations? Will it help to take an X-ray 4 or do a functional surfactant assay? 5 Hav-ଝ Please cite this article as: Dargaville PA.Administering surfactant without intubation ---what does the laryngeal mask offer us?J Pediatr (Rio J).
No takes yet. Share an insight, caveat, or question.
Peter A. Dargaville (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: